Schedule 13G ownership disclosure

Intellia Therapeutics Inc

Security class unavailable · CUSIP: 45826J105

Event date: 2016-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,429,788
Percent of class
12.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-17-007835
Form type
SC 13G
Filer
Atlas Venture Fund IX, L.P.
CIK
CIK 1671219
Filed
Feb 09, 2017
Reporting period
Dec 31, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub